• Remed set a KRW 10 billion private placement of 4th series unsecured, bearer, coupon convertible bonds.
• Proceeds earmarked for working capital, with spending focused on overseas expansion, B2C commercialization, BCI-related projects.
• Bonds carry a 1% coupon, 5% yield to maturity, with maturity set for Oct. 26, 2031.
• Conversion price set at KRW 2,954, implying up to 3,385,240 new common shares, equal to 11.18% of outstanding shares.
• Settlement scheduled for Oct. 26, 2026, with LF Investment named as the subscriber.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Remed Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261014000424), on October 14, 2026, and is solely responsible for the information contained therein.